Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

@article{Matsuzaki2005BacteriophageTA,
  title={Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases},
  author={S. Matsuzaki and M. Rashel and Jumpei Uchiyama and Shingo Sakurai and T. Ujihara and Masayuki Kuroda and M. Ikeuchi and T. Tani and M. Fujieda and H. Wakiguchi and S. Imai},
  journal={Journal of Infection and Chemotherapy},
  year={2005},
  volume={11},
  pages={211-219}
}
Bacteriophage (phage) therapy involves using phages or their products as bioagents for the treatment or prophylaxis of bacterial infectious diseases. Much evidence in support of the effectiveness of phage therapy against bacterial infectious diseases has accumulated since 1980 from animal model studies conducted in Western countries. Reports indicate that appropriate administration of living phages can be used to treat lethal infectious diseases caused by gram-negative bacteria, such as… Expand
Phage for Biocontrol
TLDR
Egged phage-based bactericidal delivery vehicles will be introduced as a treatment approach for the biocontrol of a variety of important pathogens, suitable for concurrent treatment with standard antibiotics and possibly become a suitable replacement. Expand
Exploring phage diversity and potential: Development of phage therapy for bacterial infection
TLDR
The overall objectives of this research including isolation and purification of potentially new phages from environments, characterization of the isolated phages based on morphological study, physicochemical attributes, genomic and proteomic analysis, and development into phage therapy against bacterial infection are presented. Expand
AN OVERVIEW OF BACTERIOPHAGE THERAPY OVER ANTIBIOTICS; AS AN ALTERNATIVE FOR CONTROLLING BACTERIAL INFECTIONS
Bacteriophages are particular infective agents of diverse bacteria. They are separated into different groups according to their life cycle. The lytic phages kill their host cells; this property canExpand
Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.
  • V. Fischetti
  • Biology, Medicine
  • Current topics in microbiology and immunology
  • 2017
TLDR
Lysins can eliminate bacteria both systemically and topically, from mucosal surfaces and biofilms, as evidenced by experimental models of sepsis, pneumonia, meningitis, endocarditis, and mucosal decolonization and may be a much-needed anti-infective in an age of mounting antibiotic resistance. Expand
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
TLDR
This review presents novel strategies for phage-related therapies and describes the current knowledge of natural bacteriophages within the human microbiome to provide an overview of the high number of different methodological concepts. Expand
Bacteriophage as a Therapeutic Agent to Combat Bacterial Infection: A Journey from History to Application
TLDR
This chapter is introduced to brief the concept of phage, phage history, and phage biology with highlights ofphage therapy, phages engineering, as well as phage applications including the future of phages. Expand
Bacteriophages and Phage-Derived Proteins – Application Approaches
TLDR
In this review, several issues of phage and phage-derived protein application approaches in therapy, diagnostics and biotechnology in general are discussed. Expand
Development and characterisation of a responsive polyvalent bacteriophage therapeutic
TLDR
The use of phages to target both S. aureus and P. aeruginosa pathogen biofilm producers is explored and both cocktails were shown to be effective in reducing and dispersing biofilms formed by the clinical strains, showing them to be promising not only to combat topical bacterial infections, but also to control biofilm produced on the surfaces of medical devices, such as catheters. Expand
Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
TLDR
The literature data suggest that bacteriophages, phage endolysins and antimicrobial peptides can be used in combined therapy, thus negating many of the limitations resulting from their specificity as a single antimicrobial agent. Expand
Bacteriophages as an alternative strategy for fighting biofilm development.
TLDR
Experiments showed that bacteriophages may both prevent biofilm formation and contribute to eradication of biofilm bacteria, and a specific role is played here by phage depolymerases, which facilitate the degradation of extracellular polymeric substances (EPS). Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 127 REFERENCES
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
TLDR
This study suggests that the increased survival rate of Pf3R-treated mice could result from reduced endotoxin release, and the use of a nonreplicating modified phage for the delivery of genes encoding proteins toxic to bacterial pathogens may open up a new avenue in antimicrobial therapy. Expand
Long-circulating bacteriophage as antibacterial agents.
  • C. Merril, B. Biswas, +4 authors S. Adhya
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1996
TLDR
A serial-passage technique in mice is developed to select for phage mutants able to remain in the circulatory system for longer periods of time and it is demonstrated that the long-circulating lambda mutants also have greater capability as antibacterial agents than the corresponding parental strain in animals infected with lethal doses of bacteria. Expand
Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme
TLDR
A bacteriophage (phage) lytic enzyme to remove colonizing GBS and may be used to reduce vaginal GBS colonization in pregnant women before delivery or to decontaminate newborns, thus reducing the incidence of GBS-associated neonatal meningitis and sepsis. Expand
The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection
TLDR
It was revealed that bacteriophage could be detected in the blood and internal organs of the animals within 24 hours irrespective of the route of its administration: intraperitoneal, intravenous or intranasal, and may become one of alternative antimicrobial remedies, selectively affecting infective agents. Expand
Bacteriophages show promise as antimicrobial agents.
TLDR
B bacteriophages may show promise for treating antibiotic resistant pathogens, according to a literature review of all Medline citations from 1966-1996. Expand
[The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection].
TLDR
It was revealed that bacteriophage could be detected in the blood and internal organs of the animals within 24 hours irrespective of the route of its administration: intraperitoneal, intravenous or intranasal, and may become one of alternative antimicrobial remedies, selectively affecting infective agents. Expand
Potential of the Polyvalent Anti-Staphylococcus Bacteriophage K for Control of Antibiotic-Resistant Staphylococci from Hospitals
TLDR
In in vitro inhibitory assays, a lytic bacteriophage was assessed in vitro for its ability to inhibit emerging drug-resistant Staphylococcus aureus strains from hospitals and other species of Staphyllococcus isolated from bovine infections, enforcing the principle that, while certain target bacteria may be relatively insensitive to lytic phage, this can be overcome by obtaining modified phage variants from passage of the phage through the insensitive strains. Expand
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
TLDR
The findings suggest strongly that phage lysins protect animals from bacteraemia and death, and the simultaneous attack of the pneumococcal peptidoglycan by a lysozyme and an amidase leads to a remarkable effect through enhanced destruction of the bacterial cell wall. Expand
Treatment of experimental infections of mice with bacteriophages.
  • J. Soothill
  • Biology, Medicine
  • Journal of medical microbiology
  • 1992
TLDR
Experimental infections of mice support the view that bacteriophages could be useful in the treatment of human infections caused by antibiotic-resistant strains of bacteria. Expand
In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy
TLDR
Four T4-like coliphages with broad host ranges for diarrhea-associated Escherichia coli serotypes showed a highly efficient gastrointestinal passage in adult mice when added to drinking water, apparently indicating that the resident E. coli gut flora is physically or physiologically protected against phage infection. Expand
...
1
2
3
4
5
...